Taro Pharmaceutical Industries Ltd (TARO)
42.45
-0.06
(-0.14%)
USD |
NYSE |
May 03, 16:00
42.38
-0.07
(-0.16%)
After-Hours: 20:00
Taro Pharmaceutical Industries Enterprise Value: 693.25M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 693.25M |
| May 02, 2024 | 695.51M |
| May 01, 2024 | 691.00M |
| April 30, 2024 | 694.38M |
| April 29, 2024 | 694.38M |
| April 26, 2024 | 691.37M |
| April 25, 2024 | 694.38M |
| April 24, 2024 | 683.85M |
| April 23, 2024 | 684.98M |
| April 22, 2024 | 686.11M |
| April 19, 2024 | 685.73M |
| April 18, 2024 | 683.48M |
| April 17, 2024 | 685.36M |
| April 16, 2024 | 678.22M |
| April 15, 2024 | 680.85M |
| April 12, 2024 | 677.84M |
| April 11, 2024 | 681.22M |
| April 10, 2024 | 677.84M |
| April 09, 2024 | 683.48M |
| April 08, 2024 | 677.46M |
| April 05, 2024 | 681.22M |
| April 04, 2024 | 681.22M |
| April 03, 2024 | 687.61M |
| April 02, 2024 | 681.22M |
| April 01, 2024 | 684.98M |
| Date | Value |
|---|---|
| March 28, 2024 | 689.12M |
| March 27, 2024 | 686.11M |
| March 26, 2024 | 681.60M |
| March 25, 2024 | 685.36M |
| March 22, 2024 | 679.72M |
| March 21, 2024 | 683.48M |
| March 20, 2024 | 688.74M |
| March 19, 2024 | 680.85M |
| March 18, 2024 | 674.08M |
| March 15, 2024 | 681.60M |
| March 14, 2024 | 680.10M |
| March 13, 2024 | 681.60M |
| March 12, 2024 | 675.21M |
| March 11, 2024 | 677.46M |
| March 08, 2024 | 677.46M |
| March 07, 2024 | 680.85M |
| March 06, 2024 | 637.63M |
| March 05, 2024 | 674.83M |
| March 04, 2024 | 678.22M |
| March 01, 2024 | 680.10M |
| February 29, 2024 | 678.97M |
| February 28, 2024 | 675.59M |
| February 27, 2024 | 681.22M |
| February 26, 2024 | 679.34M |
| February 23, 2024 | 678.59M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
24.95M
Minimum
Mar 28 2023
3.067B
Maximum
May 06 2019
1.152B
Average
1.082B
Median
Jan 13 2022
Enterprise Value Benchmarks
| InspireMD Inc | 7.890M |
| BiomX Inc | 17.48M |
| Alpha Tau Medical Ltd | 97.30M |
| Pluri Inc | 26.05M |
| Holdco Nuvo Group DG Ltd | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 20.21M |
| Revenue (Quarterly) | 157.14M |
| Total Expenses (Quarterly) | 141.26M |
| EPS Diluted (Quarterly) | 0.54 |
| Gross Profit Margin (Quarterly) | 50.83% |
| Profit Margin (Quarterly) | 12.86% |
| Earnings Yield | 2.87% |
| Operating Earnings Yield | 1.38% |
| Normalized Earnings Yield | 2.869 |